doi: 10.1038/nrneph.2012.264.
Epub 2012 Nov 27.
Hypertension: Synergy of antihypertensives in elderly patients with CKD
Affiliations
- PMID: 23183840
- PMCID: PMC4349578
- DOI: 10.1038/nrneph.2012.264
Item in Clipboard
Hypertension: Synergy of antihypertensives in elderly patients with CKD
Nat Rev Nephrol.
2013 Jan.
Abstract
A recent study reports that the combination of an angiotensin-receptor blocker (ARB) and a calcium-channel blocker (versus a high-dose ARB) is associated with improved blood pressure control and reduced cardiovascular, cerebrovascular and heart failure events in an elderly chronic kidney disease population. This finding raises the possibility of using fixed-dose drug combinations to improve efficacy and compliance of antihypertensive medications.
Similar articles
-
Hypertension control in chronic kidney disease: don't miss the forest for the trees.Med J Malaysia. 2012 Aug;67(4):359-62. Med J Malaysia. 2012. PMID: 23082441 No abstract available.
-
An angiotensin II receptor blocker-calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone.Kidney Int. 2013 Jan;83(1):167-76. doi: 10.1038/ki.2012.326. Epub 2012 Oct 10. Kidney Int. 2013. PMID: 23051740 Free PMC article. Clinical Trial.
-
Hypertension Management in Transition: From CKD to ESRD.Adv Chronic Kidney Dis. 2016 Jul;23(4):255-61. doi: 10.1053/j.ackd.2016.02.002. Adv Chronic Kidney Dis. 2016. PMID: 27324679 Review.
-
Pharmacologic Issues in treating hypertension in CKD.Adv Chronic Kidney Dis. 2011 Jan;18(1):42-7. doi: 10.1053/j.ackd.2010.11.003. Adv Chronic Kidney Dis. 2011. PMID: 21224029 Review.
-
Combination of angiotensin II receptor antagonist with calcium channel blocker or diuretic as antihypertensive therapy for patients with chronic kidney disease.Clin Exp Hypertens. 2011;33(6):366-72. doi: 10.3109/10641963.2010.503299. Epub 2011 Jul 28. Clin Exp Hypertens. 2011. PMID: 21797795 Clinical Trial.
Cited by
-
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.Nat Rev Endocrinol. 2016 Mar;12(3):144-53. doi: 10.1038/nrendo.2015.216. Epub 2015 Dec 18. Nat Rev Endocrinol. 2016. PMID: 26678809 Free PMC article. Review.
-
Role of mineralocorticoid receptor activation in cardiac diastolic dysfunction.Biochim Biophys Acta Mol Basis Dis. 2017 Aug;1863(8):2012-2018. doi: 10.1016/j.bbadis.2016.10.025. Epub 2016 Oct 29. Biochim Biophys Acta Mol Basis Dis. 2017. PMID: 27989961 Free PMC article. Review.
References
-
- Aronow WS, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J. Am. Coll. Cardiol. 2011;57:2037–2114. - PubMed
-
- Kim-Mitsuyama S, et al. An angiotensin II receptor blocker–calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone. Kidney Int. http://dx.doi.org/10.1038/ki.2012.326. - DOI - PMC - PubMed
-
- Wald DS, et al. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am. J. Med. 2009;122:290–300. - PubMed
-
- Safar ME, Protogerou A, Blacher J. Central blood pressure under angiotensin and calcium channel blockade. Hypertension. 2009;54:704–706. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
